While FLNA alterations coincides with the prodromal AD stage, where cognitive decline and neurodegeneration is significant (Scheff et al., 2006; Vanhaute et al., 2020), insoluble FLNA was not significantly associated with synaptophysin, VAChT, ChAT nor with any cognitive measures. The gene discussed is SLC18A3; the disease is Alzheimer disease.